Package 31722-535-01

{"route": ["ORAL"], "spl_id": "f3388e9a-2c01-de8d-e053-2a95a90aa213", "openfda": {"upc": ["0331722535304"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["1ac4c628-f01f-42d4-b8e6-d12273aefc6d"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (31722-535-01)", "package_ndc": "31722-535-01", "marketing_start_date": "20180126"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (31722-535-05)", "package_ndc": "31722-535-05", "marketing_start_date": "20180126"}, {"sample": false, "description": "1000 TABLET, FILM COATED in 1 BOTTLE (31722-535-10)", "package_ndc": "31722-535-10", "marketing_start_date": "20180126"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-535-30)", "package_ndc": "31722-535-30", "marketing_start_date": "20180126"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-535-60)", "package_ndc": "31722-535-60", "marketing_start_date": "20180126"}], "brand_name": "Tenofovir Disoproxil Fumarate", "product_id": "31722-535_f3388e9a-2c01-de8d-e053-2a95a90aa213", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "31722-535", "generic_name": "Tenofovir Disoproxil Fumarate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA090636", "marketing_category": "ANDA", "marketing_start_date": "20180126", "listing_expiration_date": "20261231"}